Borchelt DR - Search Results

1

Quantitative Comparison of Dense-Core Amyloid Plaque Accumulation in Amyloid-β Protein Precursor Transgenic Mice.

Liu P, Reichl JH, Rao ER, McNellis BM, Huang ES, Hemmy LS, Forster CL, Kuskowski MA, Borchelt DR, Vassar R, Ashe KH, Zahs KR. Liu P, et al. Among authors: borchelt dr. J Alzheimers Dis. 2017;56(2):743-761. doi: 10.3233/JAD-161027. J Alzheimers Dis. 2017. PMID: 28059792 Free PMC article.

2

Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, et al. Hsiao KK, et al. Among authors: borchelt dr. Neuron. 1995 Nov;15(5):1203-18. doi: 10.1016/0896-6273(95)90107-8. Neuron. 1995. PMID: 7576662 Free article.

3

SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein.

Iadecola C, Zhang F, Niwa K, Eckman C, Turner SK, Fischer E, Younkin S, Borchelt DR, Hsiao KK, Carlson GA. Iadecola C, et al. Among authors: borchelt dr. Nat Neurosci. 1999 Feb;2(2):157-61. doi: 10.1038/5715. Nat Neurosci. 1999. PMID: 10195200

4

Abeta deposition is essential to AD neuropathology.

Estus S, Borchelt D, Kindy MS, Vassar R. Estus S, et al. J Alzheimers Dis. 2002 Jun;4(3):133-8. doi: 10.3233/jad-2002-4302. J Alzheimers Dis. 2002. PMID: 12226531 No abstract available.

5

Passive (amyloid-β) immunotherapy attenuates monoaminergic axonal degeneration in the AβPPswe/PS1dE9 mice.

Liu Y, Lee MK, James MM, Price DL, Borchelt DR, Troncoso JC, Oh ES. Liu Y, et al. Among authors: borchelt dr. J Alzheimers Dis. 2011;23(2):271-9. doi: 10.3233/JAD-2010-101602. J Alzheimers Dis. 2011. PMID: 20966549 Free PMC article.

6

Cytosolic proteins lose solubility as amyloid deposits in a transgenic mouse model of Alzheimer-type amyloidosis.

Xu G, Stevens SM Jr, Moore BD, McClung S, Borchelt DR. Xu G, et al. Among authors: borchelt dr. Hum Mol Genet. 2013 Jul 15;22(14):2765-74. doi: 10.1093/hmg/ddt121. Epub 2013 Mar 19. Hum Mol Genet. 2013. PMID: 23512986 Free PMC article.

7

Normal cognition in transgenic BRI2-Aβ mice.

Kim J, Chakrabarty P, Hanna A, March A, Dickson DW, Borchelt DR, Golde T, Janus C. Kim J, et al. Among authors: borchelt dr. Mol Neurodegener. 2013 May 12;8:15. doi: 10.1186/1750-1326-8-15. Mol Neurodegener. 2013. PMID: 23663320 Free PMC article.

8

Comment on "ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models".

Price AR, Xu G, Siemienski ZB, Smithson LA, Borchelt DR, Golde TE, Felsenstein KM. Price AR, et al. Among authors: borchelt dr. Science. 2013 May 24;340(6135):924-d. doi: 10.1126/science.1234089. Science. 2013. PMID: 23704553

9

TAPPing into the potential of inducible tau/APP transgenic mice.

Xu G, Ulm BS, Howard J, Fromholt SE, Lu Q, Lee BB, Walker A, Borchelt DR, Lewis J. Xu G, et al. Among authors: borchelt dr. Neuropathol Appl Neurobiol. 2022 Apr;48(3):e12791. doi: 10.1111/nan.12791. Neuropathol Appl Neurobiol. 2022. PMID: 35067965

10

Modeling the Competition between Misfolded Aβ Conformers That Produce Distinct Types of Amyloid Pathology in Alzheimer's Disease.

Xu G, Fromholt S, Borchelt DR. Xu G, et al. Among authors: borchelt dr. Biomolecules. 2022 Jun 24;12(7):886. doi: 10.3390/biom12070886. Biomolecules. 2022. PMID: 35883442 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page